Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Kenvue
KVUE
|
$344M |
| 2 |
JPMorgan Chase
JPM
|
$161M |
| 3 |
Extra Space Storage
EXR
|
$134M |
| 4 |
GE HealthCare
GEHC
|
$113M |
| 5 |
Ferguson
FERG
|
$97.1M |
Top Sells
| 1 |
PDCE
PDC Energy, Inc.
PDCE
|
$313M |
| 2 |
Super Micro Computer
SMCI
|
$305M |
| 3 |
UNVR
Univar Solutions Inc.
UNVR
|
$176M |
| 4 |
LSI
Life Storage, Inc.
LSI
|
$160M |
| 5 |
Walmart
WMT
|
$112M |
Sector Composition
| 1 | Technology | 17.36% |
| 2 | Financials | 16.12% |
| 3 | Industrials | 13.02% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Healthcare | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BNR
3376
Burning Rock Biotech
BNR
$89.4M
| $53.3K | ﹤0.01% |
5,497
-593
| -10% | -$5.75K |
|
|
AFMD
3377
DELISTED
Affimed
AFMD
| $52.5K | ﹤0.01% |
10,991
-379
| -3% | -$1.81K |
|
|
WHLM
3378
DELISTED
Wilhelmina International, Inc
WHLM
| $52.5K | ﹤0.01% |
14,457
| – | – |
|
|
LUMO
3379
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $51.4K | ﹤0.01% |
15,564
-4,525
| -23% | -$14.9K |
|
3380
SES AI
SES
$395M
| $49.9K | ﹤0.01% |
+21,972
| New | +$49.9K |
|
3381
Veritone
VERI
$147M
| $49.7K | ﹤0.01% |
19,244
+12
| +0.1% | +$31 |
|
3382
SurgePays
SURG
$54.1M
| $48.8K | ﹤0.01% |
+10,432
| New | +$48.8K |
|
3383
ProPhase Labs
PRPH
$14.7M
| $48.2K | ﹤0.01% |
11,039
-13,802
| -56% | -$60.3K |
|
3384
Lineage Cell Therapeutics
LCTX
$279M
| $47.7K | ﹤0.01% |
40,449
| – | – |
|
|
IMAB
3385
I-MAB
IMAB
$358M
| $47.7K | ﹤0.01% |
36,123
| – | – |
|
3386
Abeona Therapeutics
ABEO
$353M
| $47.1K | ﹤0.01% |
11,196
-1,795
| -14% | -$7.56K |
|
3387
Electro-Sensors
ELSE
$16.3M
| $45.6K | ﹤0.01% |
11,461
| – | – |
|
|
VTNR
3388
DELISTED
Vertex Energy, Inc
VTNR
| $45.3K | ﹤0.01% |
+10,188
| New | +$45.3K |
|
3389
Gold Resource Corp
GORO
$103M
| $44K | ﹤0.01% |
102,935
-276,182
| -73% | -$118K |
|
3390
Intellicheck
IDN
$107M
| $43.8K | ﹤0.01% |
19,751
| – | – |
|
3391
DiaMedica Therapeutics
DMAC
$317M
| $43.8K | ﹤0.01% |
16,959
| – | – |
|
|
OMGA
3392
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $41.9K | ﹤0.01% |
19,505
-3,239
| -14% | -$6.96K |
|
|
BFX
3393
DELISTED
BowFlex Inc.
BFX
| $41.5K | ﹤0.01% |
49,009
-288,094
| -85% | -$244K |
|
3394
One Stop Systems
OSS
$126M
| $41.2K | ﹤0.01% |
22,257
-52,767
| -70% | -$97.6K |
|
3395
Immix Biopharma
IMMX
$62M
| $40.7K | ﹤0.01% |
11,915
+4
| +0% | +$14 |
|
3396
Trevi Therapeutics
TRVI
$854M
| $40.1K | ﹤0.01% |
+18,382
| New | +$40.1K |
|
3397
Absci
ABSI
$368M
| $40K | ﹤0.01% |
30,315
-8,884
| -23% | -$11.7K |
|
3398
Coffee Holding Co
JVA
$23.7M
| $39K | ﹤0.01% |
45,084
-19,020
| -30% | -$16.5K |
|
3399
Ocular Therapeutix
OCUL
$2.37B
| $38.9K | ﹤0.01% |
12,389
-11,930
| -49% | -$37.5K |
|
|
GP
3400
GreenPower Motor Co
GP
$7.15M
| $38.7K | ﹤0.01% |
+12,298
| New | +$38.7K |
|